[
Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial
[og_img]
https://www.investing.com/news/stock-market-news/eli-lillys-zepbound-outperforms-novo-nordisks-wegovy-for-weight-loss-in-trial-4037773
Reuters
Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial
Related articles
